HOUSTON, January 14 /PRNewswire/ --
- Expert Faculty to Present Updates on the Latest Neuroscience Research and Clinical Treatments
The University of Texas M. D. Anderson Cancer Center and St. Luke's Episcopal Hospital, renowned institutions from Houston's Texas Medical Center, announced the first Neuroscience Frontiers Conference, which will take place at the Grand Hyatt in Dubai, United Arab Emirates (UAE), on January 21, 2008.
The event will offer a forum for the exchange of the latest neuroscience developments and therapies among faculty at both institutions and leading researchers and clinicians in the Middle East, with the ultimate goal of advancing collaboration for the benefit of patients with disorders such as brain tumors, movement disorders and cerebrovascular disease. This conference is under the patronage of the Ministry of Health of United Arab Emirates, H.E. Humaid Mohamed Al Qutami.
"The study and care of patients facing disorders of the central nervous system is a rapidly advancing and multifaceted field. Neuroscience Frontiers reinforces our commitment to building upon the collective depth and breadth of neuroscience programs in the Texas Medical Center and the Middle East for the benefit of patients everywhere," said Raymond Sawaya, M.D., professor and chair of the Department of Neurosurgery at M. D. Anderson.
"We are excited to participate in the launch of Neuroscience Frontiers to promote a greater understanding of medical conditions that impact the body's nervous system," said Michel E. Mawad, M.D., Associate Service Chief of Radiology and Director of Neurovascular Radiology at the NeuroScience Center at St. Luke's Episcopal Hospital and professor and chair of the Department of Radiology, Baylor College of Medicine.
Drs. Sawaya and Mawad and colleagues from both institutions will present at Neuroscience Frontiers. Basim A. Yaqub, M.D., the head of Neurology and Neurophysiology at Dr. Sulaiman Al-Habib Medical Center in Riyadh, Saudi Arabia, will be a guest speaker.
Presentation topics will include surgical management of malignant brain tumors and skull base tumors; management of brain metastases; spinal oncology; epilepsy; the role of surgery in movement disorders; cerebral aneurysms and vascular malformations.
Neuroscience Frontiers has been approved for AMA/PRA Category 1 Credit(TM) by the Accreditation Council for Continuing Medical Education (ACCME). Event, registration and additional contact information may be found at www.neurofrontiers.com or by calling +971-4-361-6291 in Dubai, UAE.
M. D. Anderson Cancer Center, one of the world's preeminent centers for cancer patient care, research, education and prevention, was designated by the National Cancer Institute (NCI) as one of the first three Comprehensive Cancer Centers in the United States. In 2007, U.S. News & World Report's "America's Best Hospitals" survey ranked M. D. Anderson as the top hospital in the nation for cancer care, the fifth time in eight years that the institution has achieved the highest ranking. M. D. Anderson has provided care for more than 700,000 cancer patients since 1944 and 74,000 in the last year alone.
St. Luke's Episcopal Health System comprises the flagship St. Luke's Episcopal Hospital in the Texas Medical Center, founded in 1954 by the Episcopal Diocese of Texas; St. Luke's Community Medical Center; St. Luke's Episcopal Health Charities, a charity devoted to assessing and enhancing community health, especially among the underserved; and Kelsey-Seybold Management, LLP, overseeing 18 clinic locations. St. Luke's Episcopal Hospital is home to the Texas Heart(R) Institute, founded in 1962 by Denton A. Cooley, MD, and is consistently ranked among the top 10 cardiology and heart surgery centers in the nation by U .S. News & World Report.
Web site: http://www.mdanderson.org http://wwws.sleh.com/NeuroFrontiers/index.html http://www.neurofrontiers.com
Robyn Stein for M. D. Anderson Cancer Center, +1-212-220-4444, robyn.stein@gabbe.com
Comments